Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXW8XC
|
||||
| Drug Name |
[3-(5-Fluoro-1H-indol-3-yl)-propyl]-[2-(5-fluoro-2-methoxy-phenoxy)-ethyl]-amine
|
||||
| Synonyms |
CHEMBL127171
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H22F2N2O2
|
||||
| Canonical SMILES |
COc1ccc(F)cc1OCCNCCCc2c[nH]c3ccc(F)cc23
|
||||
| InChI |
InChI=1S/C20H22F2N2O2/c1-25-19-7-5-16(22)12-20(19)26-10-9-23-8-2-3-14-13-24-18-6-4-15(21)11-17(14)18/h4-7,11-13,23-24H,2-3,8-10H2,1H3
|
||||
| InChIKey |
JVZKOTRMFQSGLN-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.